will pfizer buy exact sciences?
Global pharmaceutical company Pfizer Inc. has entered into a four-year agreement with Exact Sciences Corp. to co-promote and sell the Madison company's noninvasive stool DNA-based colorectal cancer take-home test in the United States. The agreement takes effect in the fourth quarter of 2018.